Recent Product Innovation Kemin has recently launched new application systems and vaccines, including the EDIE generation 2 for livestock and the MEVAC MULTI ADENO vaccine for poultry, demonstrating ongoing innovation and a focus on animal health solutions that present upselling opportunities.

Strategic Asset Divestiture The sale of Kemin Crop Technologies assets to AgroPlantae indicates a strategic shift towards core areas like human nutrition and animal health, allowing sales teams to focus on expanding these high-growth segments.

Market Engagement Kemin actively participates in industry events such as IPPE and the International Production & Processing Expo, providing opportunities to network with potential clients in the food processing, animal, and crop industries.

Innovation in Crop Technology The launch of Valena FLOW highlights Kemin's investment in plant growth and crop quality solutions, creating potential sales avenues within sustainable agriculture and crop enhancement markets.

Financial Position and Growth With revenue estimates between 10 and 25 million dollars, Kemin is positioned as a growing midsize company, making it a viable target for sales of targeted nutritional, supplement, and animal health solutions.